Fatty acid intake and incident nephrolithiasis.
Identifieur interne : 000448 ( Main/Exploration ); précédent : 000447; suivant : 000449Fatty acid intake and incident nephrolithiasis.
Auteurs : Eric N. Taylor [États-Unis] ; Meir J. Stampfer ; Gary C. CurhanSource :
- American journal of kidney diseases : the official journal of the National Kidney Foundation [ 1523-6838 ] ; 2005.
Descripteurs français
- KwdFr :
- Acide arachidonique (métabolisme), Acide linoléique (métabolisme), Acides gras (métabolisme), Acides gras omega-3 (métabolisme), Adulte (MeSH), Adulte d'âge moyen (MeSH), Dentistes (statistiques et données numériques), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Huiles de poisson (métabolisme), Humains (MeSH), Infirmières et infirmiers (statistiques et données numériques), Matières grasses alimentaires (métabolisme), Mâle (MeSH), Médecins (statistiques et données numériques), Néphrocalcinose (épidémiologie), Pharmaciens (statistiques et données numériques), Sujet âgé (MeSH), Vétérinaires (statistiques et données numériques), Études prospectives (MeSH).
- MESH :
- métabolisme : Acide arachidonique, Acide linoléique, Acides gras, Acides gras omega-3, Huiles de poisson, Matières grasses alimentaires.
- statistiques et données numériques : Dentistes, Infirmières et infirmiers, Médecins, Pharmaciens, Vétérinaires.
- épidémiologie : Néphrocalcinose.
- Adulte, Adulte d'âge moyen, Enquêtes et questionnaires, Femelle, Humains, Mâle, Sujet âgé, Études prospectives.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Arachidonic Acid (metabolism), Dentists (statistics & numerical data), Dietary Fats (metabolism), Fatty Acids (metabolism), Fatty Acids, Omega-3 (metabolism), Female (MeSH), Fish Oils (metabolism), Humans (MeSH), Linoleic Acid (metabolism), Male (MeSH), Middle Aged (MeSH), Nephrocalcinosis (epidemiology), Nurses (statistics & numerical data), Pharmacists (statistics & numerical data), Physicians (statistics & numerical data), Prospective Studies (MeSH), Surveys and Questionnaires (MeSH), Veterinarians (statistics & numerical data).
- MESH :
- chemical , metabolism : Arachidonic Acid, Dietary Fats, Fatty Acids, Fatty Acids, Omega-3, Fish Oils, Linoleic Acid.
- epidemiology : Nephrocalcinosis.
- statistics & numerical data : Dentists, Nurses, Pharmacists, Physicians, Veterinarians.
- Adult, Aged, Female, Humans, Male, Middle Aged, Prospective Studies, Surveys and Questionnaires.
Abstract
BACKGROUND
Elevated levels of arachidonic acid in cell membranes may promote the hypercalciuria and hyperoxaluria that are characteristic of idiopathic calcium nephrolithiasis. The intake of n-3 fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may decrease the arachidonic acid content of cell membranes and reduce urinary excretion of calcium and oxalate. It has been proposed that greater intake of EPA and DHA (through dietary sources or fish oil supplementation) may reduce the risk for kidney stone formation.
METHODS
After excluding subjects with a prior history of kidney stones, we prospectively examined the relation between fatty acid intake (including fish oil supplements) and incident symptomatic kidney stones in 3 large cohorts: the Health Professionals Follow-Up Study (N = 46,043), the Nurses' Health Study I (NHS I; N = 92,079), and the Nurses' Health Study II (N = 96,304). Self-administered food-frequency questionnaires were used to assess fatty acid intake every 4 years. Cox proportional hazards regression was used to adjust simultaneously for a variety of risk factors.
RESULTS
We documented 3,956 incident kidney stones during a combined 36 years of follow-up. After adjustment for intake of other dietary factors, no association was detected between the intake of arachidonic acid or linoleic acid (a metabolic precursor to arachidonic acid) and the risk for incident kidney stones. Older women (NHS I) in the highest quintile of EPA and DHA intake had a multivariate relative risk of 1.28 (95% confidence interval, 1.04 to 1.56; P for trend = 0.04) of stone formation compared with women in the lowest quintile. However, this relation was not observed in the other 2 cohorts.
CONCLUSION
Fatty acid intake is not consistently associated with the development of kidney stones. Greater levels of arachidonic and linoleic acid intake do not increase the risk for developing a kidney stone, and greater intake of n-3 fatty acids does not reduce the risk.
DOI: 10.1053/j.ajkd.2004.09.026
PubMed: 15685503
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fatty acid intake and incident nephrolithiasis.</title><author><name sortKey="Taylor, Eric N" sort="Taylor, Eric N" uniqKey="Taylor E" first="Eric N" last="Taylor">Eric N. Taylor</name><affiliation wicri:level="2"><nlm:affiliation>Channing Laboratory and Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. entaylor@partners.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Channing Laboratory and Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Stampfer, Meir J" sort="Stampfer, Meir J" uniqKey="Stampfer M" first="Meir J" last="Stampfer">Meir J. Stampfer</name></author><author><name sortKey="Curhan, Gary C" sort="Curhan, Gary C" uniqKey="Curhan G" first="Gary C" last="Curhan">Gary C. Curhan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15685503</idno><idno type="pmid">15685503</idno><idno type="doi">10.1053/j.ajkd.2004.09.026</idno><idno type="wicri:Area/Main/Corpus">000456</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000456</idno><idno type="wicri:Area/Main/Curation">000456</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000456</idno><idno type="wicri:Area/Main/Exploration">000456</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Fatty acid intake and incident nephrolithiasis.</title><author><name sortKey="Taylor, Eric N" sort="Taylor, Eric N" uniqKey="Taylor E" first="Eric N" last="Taylor">Eric N. Taylor</name><affiliation wicri:level="2"><nlm:affiliation>Channing Laboratory and Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. entaylor@partners.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Channing Laboratory and Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Stampfer, Meir J" sort="Stampfer, Meir J" uniqKey="Stampfer M" first="Meir J" last="Stampfer">Meir J. Stampfer</name></author><author><name sortKey="Curhan, Gary C" sort="Curhan, Gary C" uniqKey="Curhan G" first="Gary C" last="Curhan">Gary C. Curhan</name></author></analytic><series><title level="j">American journal of kidney diseases : the official journal of the National Kidney Foundation</title><idno type="eISSN">1523-6838</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Arachidonic Acid (metabolism)</term><term>Dentists (statistics & numerical data)</term><term>Dietary Fats (metabolism)</term><term>Fatty Acids (metabolism)</term><term>Fatty Acids, Omega-3 (metabolism)</term><term>Female (MeSH)</term><term>Fish Oils (metabolism)</term><term>Humans (MeSH)</term><term>Linoleic Acid (metabolism)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Nephrocalcinosis (epidemiology)</term><term>Nurses (statistics & numerical data)</term><term>Pharmacists (statistics & numerical data)</term><term>Physicians (statistics & numerical data)</term><term>Prospective Studies (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term><term>Veterinarians (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acide arachidonique (métabolisme)</term><term>Acide linoléique (métabolisme)</term><term>Acides gras (métabolisme)</term><term>Acides gras omega-3 (métabolisme)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Dentistes (statistiques et données numériques)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Femelle (MeSH)</term><term>Huiles de poisson (métabolisme)</term><term>Humains (MeSH)</term><term>Infirmières et infirmiers (statistiques et données numériques)</term><term>Matières grasses alimentaires (métabolisme)</term><term>Mâle (MeSH)</term><term>Médecins (statistiques et données numériques)</term><term>Néphrocalcinose (épidémiologie)</term><term>Pharmaciens (statistiques et données numériques)</term><term>Sujet âgé (MeSH)</term><term>Vétérinaires (statistiques et données numériques)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Arachidonic Acid</term><term>Dietary Fats</term><term>Fatty Acids</term><term>Fatty Acids, Omega-3</term><term>Fish Oils</term><term>Linoleic Acid</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Nephrocalcinosis</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Acide arachidonique</term><term>Acide linoléique</term><term>Acides gras</term><term>Acides gras omega-3</term><term>Huiles de poisson</term><term>Matières grasses alimentaires</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Dentists</term><term>Nurses</term><term>Pharmacists</term><term>Physicians</term><term>Veterinarians</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Dentistes</term><term>Infirmières et infirmiers</term><term>Médecins</term><term>Pharmaciens</term><term>Vétérinaires</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Néphrocalcinose</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Elevated levels of arachidonic acid in cell membranes may promote the hypercalciuria and hyperoxaluria that are characteristic of idiopathic calcium nephrolithiasis. The intake of n-3 fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may decrease the arachidonic acid content of cell membranes and reduce urinary excretion of calcium and oxalate. It has been proposed that greater intake of EPA and DHA (through dietary sources or fish oil supplementation) may reduce the risk for kidney stone formation.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>After excluding subjects with a prior history of kidney stones, we prospectively examined the relation between fatty acid intake (including fish oil supplements) and incident symptomatic kidney stones in 3 large cohorts: the Health Professionals Follow-Up Study (N = 46,043), the Nurses' Health Study I (NHS I; N = 92,079), and the Nurses' Health Study II (N = 96,304). Self-administered food-frequency questionnaires were used to assess fatty acid intake every 4 years. Cox proportional hazards regression was used to adjust simultaneously for a variety of risk factors.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>We documented 3,956 incident kidney stones during a combined 36 years of follow-up. After adjustment for intake of other dietary factors, no association was detected between the intake of arachidonic acid or linoleic acid (a metabolic precursor to arachidonic acid) and the risk for incident kidney stones. Older women (NHS I) in the highest quintile of EPA and DHA intake had a multivariate relative risk of 1.28 (95% confidence interval, 1.04 to 1.56; P for trend = 0.04) of stone formation compared with women in the lowest quintile. However, this relation was not observed in the other 2 cohorts.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Fatty acid intake is not consistently associated with the development of kidney stones. Greater levels of arachidonic and linoleic acid intake do not increase the risk for developing a kidney stone, and greater intake of n-3 fatty acids does not reduce the risk.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15685503</PMID><DateCompleted><Year>2005</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2005</Year><Month>Feb</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Fatty acid intake and incident nephrolithiasis.</ArticleTitle><Pagination><MedlinePgn>267-74</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Elevated levels of arachidonic acid in cell membranes may promote the hypercalciuria and hyperoxaluria that are characteristic of idiopathic calcium nephrolithiasis. The intake of n-3 fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may decrease the arachidonic acid content of cell membranes and reduce urinary excretion of calcium and oxalate. It has been proposed that greater intake of EPA and DHA (through dietary sources or fish oil supplementation) may reduce the risk for kidney stone formation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">After excluding subjects with a prior history of kidney stones, we prospectively examined the relation between fatty acid intake (including fish oil supplements) and incident symptomatic kidney stones in 3 large cohorts: the Health Professionals Follow-Up Study (N = 46,043), the Nurses' Health Study I (NHS I; N = 92,079), and the Nurses' Health Study II (N = 96,304). Self-administered food-frequency questionnaires were used to assess fatty acid intake every 4 years. Cox proportional hazards regression was used to adjust simultaneously for a variety of risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We documented 3,956 incident kidney stones during a combined 36 years of follow-up. After adjustment for intake of other dietary factors, no association was detected between the intake of arachidonic acid or linoleic acid (a metabolic precursor to arachidonic acid) and the risk for incident kidney stones. Older women (NHS I) in the highest quintile of EPA and DHA intake had a multivariate relative risk of 1.28 (95% confidence interval, 1.04 to 1.56; P for trend = 0.04) of stone formation compared with women in the lowest quintile. However, this relation was not observed in the other 2 cohorts.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Fatty acid intake is not consistently associated with the development of kidney stones. Greater levels of arachidonic and linoleic acid intake do not increase the risk for developing a kidney stone, and greater intake of n-3 fatty acids does not reduce the risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Eric N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Channing Laboratory and Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. entaylor@partners.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stampfer</LastName><ForeName>Meir J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Curhan</LastName><ForeName>Gary C</ForeName><Initials>GC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA50385</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA55075</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA87969</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK07791</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK59583</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004041">Dietary Fats</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005395">Fish Oils</NameOfSubstance></Chemical><Chemical><RegistryNumber>27YG812J1I</RegistryNumber><NameOfSubstance UI="D016718">Arachidonic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9KJL21T0QJ</RegistryNumber><NameOfSubstance UI="D019787">Linoleic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016718" MajorTopicYN="N">Arachidonic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003815" MajorTopicYN="N">Dentists</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004041" MajorTopicYN="N">Dietary Fats</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015525" MajorTopicYN="N">Fatty Acids, Omega-3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005395" MajorTopicYN="N">Fish Oils</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019787" MajorTopicYN="N">Linoleic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009397" MajorTopicYN="N">Nephrocalcinosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009726" MajorTopicYN="N">Nurses</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="N">Pharmacists</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018634" MajorTopicYN="N">Veterinarians</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>9</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15685503</ArticleId><ArticleId IdType="pii">S0272638604014131</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2004.09.026</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><noCountry><name sortKey="Curhan, Gary C" sort="Curhan, Gary C" uniqKey="Curhan G" first="Gary C" last="Curhan">Gary C. Curhan</name><name sortKey="Stampfer, Meir J" sort="Stampfer, Meir J" uniqKey="Stampfer M" first="Meir J" last="Stampfer">Meir J. Stampfer</name></noCountry><country name="États-Unis"><region name="Massachusetts"><name sortKey="Taylor, Eric N" sort="Taylor, Eric N" uniqKey="Taylor E" first="Eric N" last="Taylor">Eric N. Taylor</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000448 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000448 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15685503
|texte= Fatty acid intake and incident nephrolithiasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15685503" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |